Urine telomerase for diagnosis and surveillance of bladder cancer

Advances in Urology

Volumn , Issue , 2012, Pages

  Lamarca, Angela ^a   Barriuso, Jorge ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864935205     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2012/693631     Document Type: Review

References (62)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics CA Cancer Journal for Clinicians 2011 61 2 69 90
2. Castellano D., Carles J., Esteban E., Trigo J. M., Climent M., Maroto J. P., Garca del Muro X., Font A., Paz-Ares L., Arranz J., Bellmunt J., Recommendations for the optimal management of early and advanced urothelial carcinoma Cancer Treatment Reviews 2012 38 5 431 441
3. Bellmunt J., Orsola A., Wiegel T., Guix M., De santis M., Kataja V., Bladder cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Annals of Oncology 2011 22 supplement 6 vi45 vi49
4. von Der Maase H., Pemetrexed in transitional cell carcinoma of the urothelium Oncology 2004 18 13, supplement 48 50
5. Von Der Maase H., Gemcitabine-containing regimens in bladder cancer: A new standard of care Seminars in Oncology 2001 28 3, supplement 10 1 3
6. Bellmunt J., Théodore C., Demkov T., Komyakov B., Sengelov L., Daugaard G., Caty A., Carles J., Jagiello-Gruszfeld A., Karyakin O., Delgado F. M., Hurteloup P., Winquist E., Morsli N., Salhi Y., Culine S., Von Der Maase H., Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract Journal of Clinical Oncology 2009 27 27 4454 4461
7. Mitra A. P., Cote R. J., Molecular screening for bladder cancer: progress and potential Nature Reviews Urology 2010 7 1 11 20
8. Tilki D., Burger M., Dalbagni G., Grossman H. B., Hakenberg O. W., Palou J., Reich O., Rouprt M., Shariat S. F., Zlotta A. R., Urine markers for detection and surveillance of non-muscle-invasive bladder cancer European Urology 2011 60 3 484 492
9. Cheng Z. Z., Corey M. J., Prepalo M., Majno S., Hellwage J., Zipfel P. F., Kinders R. J., Raitanen M., Meri S., Sakari Jokiranta T., Complement factor H as a marker for detection of bladder cancer Clinical Chemistry 2005 51 5 856 863 (Pubitemid 40577922)
10. Gibanel R., Ribal M. J., Filella X., Ballesta A. M., Molina R., Alcaraz A., Alcover J. B., BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder Anticancer Research 2002 22 2 B 1157 1160 (Pubitemid 34836166)
11. Raitanen M. P., The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies World Journal of Urology 2008 26 1 45 50
12. Schwarz S., Rechenmacher M., Filbeck T., Knuechel R., Blaszyk H., Hartmann A., Brockhoff G., Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions Journal of Clinical Pathology 2008 61 3 272 277 (Pubitemid 351354228)
13. Sarosdy M. F., Schellhammer P., Bokinsky G., Kahn P., Chao R., Yore L., Zadra J., Burzon D., Osher G., Bridge J. A., Anderson S., Johansson S. L., Lieber M., Soloway M., Flom K., Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer Journal of Urology 2002 168 5 1950 1954
14. Berger A. P., Parson W., Stenzl A., Steiner H., Bartsch G., Klocker H., Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue European Urology 2002 41 5 532 539
15. Lokeshwar V. B., Selzer M. G., Urinary bladder tumor markers Urologic Oncology 2006 24 6 528 537 (Pubitemid 44810015)
16. Choi H. S., Lee S. I., Kim D. J., Jeong T. Y., Usefulness of the NMP22BladderChek test for screening and follow-up of bladder cancer Korean Journal of Urology 2010 51 2 88 93
17. Shariat S. F., Savage C., Chromecki T. F., Sun M., Scherr D. S., Lee R. K., Lughezzani G., Remzi M., Marberger M. J., Karakiewicz P. I., Vickers A. J., Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology Cancer 2011 117 13 2892 2897
18. Attallah A. M., Sakr H. A., Ismail H., Abdel-Hady E. S. K., El-Dosoky I., An office-based immunodiagnostic assay for detecting urinary nuclear matrix protein 52 in patients with bladder cancer British Journal of Urology International 2005 96 3 334 339 (Pubitemid 41097678)
19. Getzenberg R. H., Konety B. R., Oeler T. A., Quigley M. M., Hakam A., Becich M. J., Bahnson R. R., Bladder cancer-associated nuclear matrix proteins Cancer Research 1996 56 7 1690 1694 (Pubitemid 26104035)
20. Snchez-Carbayo M., Herrero E., Megas J., Mira A., Soria F., Comparative sensitivity of urinary cyfra 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer Journal of Urology 1999 162 6 1951 1956
21. Fatela-Cantillo D., Fernndez-Surez A., Menéndez V., Galn J. A., Filella X., Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients Journal of Clinical Laboratory Analysis 2005 19 4 167 171 (Pubitemid 41060223)
22. Lokeshwar V. B., bek C., Pham H. T., Wei D., Young M. J., Duncan R. C., Soloway M. S., Block N. L., Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade Journal of Urology 2000 163 1 348 356
23. Passerotti C. C., Srougi M., Bomfim A. C., Martins J. R. M., Leite K. R. M., dos Reis S. T., Sampaio L. O., Ortiz V., Dietrich C. P., Nader H. B., Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma Urologic Oncology 2009 29 6 710 715
24. Margulis V., Lotan Y., Shariat S. F., Survivin: A promising biomarker for detection and prognosis of bladder cancer World Journal of Urology 2008 26 1 59 65
25. Tsihlias J., Grossman H. B., The utility of fibrin/fibrinogen degradation products in superficial bladder cancer Urologic Clinics of North America 2000 27 1 39 46 (Pubitemid 30085996)
26. Gilbert S. M., Veltri R. W., Sawczuk A., Shabsigh A., Knowles D. R., Bright S., O'Dowd G. J., Olsson C. A., Benson M. C., Sawczuk I. S., Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer Urology 2003 61 3 539 543 (Pubitemid 36294186)
27. Sheinfeld J., Reuter V. E., Melamed M. R., Fair W. R., Morse M., Sogani P. C., Herr H. W., Whitmore W. F., Cordon-Cardo C., Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation Journal of Urology 1990 143 2 285 288 (Pubitemid 20066371)
28. Mowatt G., Zhu S., Kilonzo M., Boachie C., Fraser C., Griffiths T. R. L., N'Dow J., Nabi G., Cook J., Vale L., Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer Health Technology Assessment 2010 14 4 1 4
29. Herman M. P., Svatek R. S., Lotan Y., Karakiewizc P. I., Shariat S. F., Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer Minerva Urologica e Nefrologica 2008 60 4 217 235
30. Bennett A., Telomerase and other novel approaches to bladder cancer detection Clinical Laboratory Science 2008 21 3 185 192
31. Parker J., Spiess P. E., Current and emerging bladder cancer urinary biomarkers TheScientificWorldJournal 2011 11 1103 1112
32. Stewart S. A., Bertuch A. A., The role of telomeres and telomerase in cancer research Cancer Research 2010 70 19 7365 7371
33. Artandi S. E., DePinho R. A., Telomeres and telomerase in cancer Carcinogenesis 2009 31 1 9 18
34. Donate L. E., Blasco M. A., Telomeres in cancer and ageing Philosophical Transactions of the Royal Society B 2011 366 1561 76 84
35. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation Cell 2011 144 5 646 674
36. Brandt S., TERT over-expression affects the growth of myocardial tissue derived from mouse embryonic stem cells Differentiation 2010 79 1 1 8
37. Chen Y., Kong Q., Nuclear translocation of telomerase reverse transcriptase: A critical process in chemical induced hepatocellular carcinogenesis Neoplasma 2010 57 3 222 227
38. Chen C. H., Chen R. J., Prevalence of telomerase activity in human cancer Journal of the Formosan Medical Association 2011 110 5 275 289
39. Lee C.-C., Huang K.-F., Chang D.-M., Hsu J.-J., Huang F.-C., Shih K.-N., Chen C.-L., Chen T.-C., Chen R.-H., Lin J.-J., Huang H.-S., Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones European Journal of Medicinal Chemistry 2012 50 102 112
40. D'Ambrosio D., Reichenbach P., Micheli E., Alvino A., Franceschin M., Savino M., Lingner J., Specific binding of telomeric G-quadruplexes by hydrosoluble perylene derivatives inhibits repeat addition processivity of human telomerase Biochimie 2012 94 3 854 863
41. Henson J. D., Cao Y., Huschtscha L. I., Chang A. C., Au A. Y. M., Pickett H. A., Reddel R. R., DNA C-circles are specific and quantifiable markers of alternative- lengthening-of-telomeres activity Nature Biotechnology 2009 27 12 1181 1185
42. Lee Y. S., Tae K., Lee S. H., Cho S. H., Jeong J. H., Min H. J., Ji Y. B., Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: A pilot study Clinical and Translational Oncology 2011 13 10 747 752
43. Liu Y., Wu B. Q., Zhong H. H., Xu M. L., Fang W. G., Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol Pathology International 2010 60 5 386 394
44. zmen B., Duvan C. I., Gm G., Snmezer M., Gungor M., Orta F., The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: A prospective clinical study European Journal of Gynaecological Oncology 2009 30 3 303 308
45. Xin H., Telomeric repeat amplification protocol: measuring the activity of the telomerase Methods in Molecular Biology 2011 735 107 111
46. McCleary-Wheeler A. L., Williams L. E., Hess P. R., Suter S. E., Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine American Journal of Veterinary Research 2010 71 12 1468 1474
47. Casadio V., Bravaccini S., Gunelli R., Nanni O., Zoli W., Amadori D., Calistri D., Silvestrini R., Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients International Journal of Biological Markers 2009 24 4 253 257
48. Morsi M. I., Youssef A. I., Hassouna M. E., El-Sedafi A. S., Ghazal A. A., Zaher E. R., Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients Journal of the Egyptian National Cancer Institute 2006 18 1 82 92
49. Wang J., Wu L., Ren J., Qu X., Visualizing human telomerase activity with primer-modified Au nanoparticles Small 2012 8 2 259 264
50. Iwabuchi I., Mori K., Yamamoto H., Hatakeyama S., Yoneyama T., Hashimoto Y., Koie T., Kamimura N., Suzuki T., Ohyama C., Significance of A simple assay of urine telomerase activity for the detection of bladder cancer Acta Urologica Japonica 2010 56 10 551 557
51. Eissa S., Swellam M., Amin A., Balbaa M. E., Yacout G. A., El-Zayat T. M., The clinical relevance of urine-based markers for diagnosis of bladder cancer Medical Oncology 2011 28 2 513 518
52. Brems-Eskildsen A. S., Zieger K., Toldbod H., Holcomb C., Higuchi R., Mansilla F., Munksgaard P. P., Borre M., rntoft T. F., Dyrskjt L., Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts BMC Cancer 2010 10, article 646
53. Svinareva L. V., Glukhov A. I., Zimnik O. V., Bykov I. I., Khorobrykh T. V., Shvets V. I., Detection of telomerase activity in gastric cancer Biomeditsinskaya Khimiya 2010 56 5 602 608
54. Silvestrini R., Bravaccini S., Casadio V., Amadori D., Calistri D., The current role of telomerase in the diagnosis of bladder cancer Indian Journal of Urology 2009 25 1 40 46
55. Eissa S., Swellam M., Ali-Labib R., Mansour A., El-Malt O., Tash F. M., Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer Journal of Urology 2007 178 3 1068 1072 (Pubitemid 47211050)
56. Bravaccini S., Casadio V., Gunelli R., Bucchi L., Zoli W., Amadori D., Silvestrini R., Calistri D., Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients Annals of Oncology 2011 22 10 2294 2298
57. Sanchini M. A., Gunelli R., Nanni O., Bravaccini S., Fabbri C., Sermasi A., Bercovich E., Ravaioli A., Amadori D., Calistri D., Relevance of urine telomerase in the diagnosis of bladder cancer Journal of the American Medical Association 2005 294 16 2052 2056 (Pubitemid 41539938)
58. Okumura A., Mizuno I., Nagakawa O., Fuse H., Telomerase activity is correlated with lower grade and lower stage bladder carcinomas International Journal of Urology 2004 11 12 1082 1086 (Pubitemid 40053008)
59. Dettlaff-Pokora A., Matuszewski M., Schlichtholz B., Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer Cancer Letters 2005 222 1 83 88 (Pubitemid 40544850)
60. Bravaccini S., Sanchini M. A., Granato A. M., Gunelli R., Nanni O., Amadori D., Calistri D., Silvestrini R., Urine telomerase activity for the detection of bladder cancer in females Journal of Urology 2007 178 1 57 61 (Pubitemid 46908728)
61. Calistri D., Sanchini A., Amadori D., Silvestrini R., Telomerase activity: A molecular marker for early diagnosis of bladder tumor Recenti Progressi in Medicina 2007 98 2 74 78 (Pubitemid 46423355)
62. Campos-Fernandes J. L., Descotes F., André J., Perrln P., Devonec M., Ruffion A., Value of urinary markers in the diagnosis and follow-up of urothelial bladder tumours Progres en Urologie 2007 17 1 23 34